http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101094309-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-43
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-08
filingDate 2009-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2011-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101094309-B1
titleOfInvention Method for producing target-oriented particles by enzyme synthesis
abstract The present invention relates to a preparation agent for selectively binding to a specific cell and a method for preparing a particle for drug delivery, wherein the biodegradable, biocompatible PHA synthesized through a PHA synthetase fused with a specific ligand, blocks with the PHA synthetase The copolymer is formed and nanoparticles are made through self-assembly according to the amphipathic properties of them, which is a simple method of preparing nanoparticles to which target ability to selectively bind specific cells of the body such as cancer cells. And nanoparticles for drug delivery.n n n n DDS, PHA, PHB, Integrin, RGD4C, Nano, Cancer Cell, Drug Delivery, Particle, Target
priorityDate 2009-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100481125-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ52728
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12822
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100033828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426385234
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID38769
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18218191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457754985
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45366
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID80781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18218231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3037032
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO66392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187888
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45367
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426384733
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525440
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266552
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45370
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID564123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414861628
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552868
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65182
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13019623
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP50176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415869221
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1113
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID644065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426383179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6971058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415810375
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584058
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12652

Total number of triples: 55.